List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 5418 studies with search of:   Canada
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Natalizumab
2 Completed Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Adalimumab
3 Completed A New Oral Treatment For Type II Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: GW0823093
4 Completed Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
Condition: Osteoarthritis, Knee
Intervention: Drug: GW406381
5 Active, not recruiting Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
6 Completed Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
Conditions: Dysmenorrhea;   Dyspareunia;   Endometriosis;   Pelvic Pain
Intervention: Drug: ERB-041
7 Completed Safety Study of Apixaban in Recent Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Interventions: Drug: Apixaban;   Drug: Apixaban;   Drug: Placebo
8 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
9 Recruiting Temozolomide and Everolimus in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus;   Drug: temozolomide;   Procedure: adjuvant therapy;   Procedure: gene expression profiling;   Procedure: immunohistochemistry staining method;   Procedure: pharmacological study
10 Active, not recruiting A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin
Conditions: Non-Insulin-Dependent Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention: Drug: Rosiglitazone maleate/metformin hydrochloride (AVANDAMET)
11 Recruiting Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)
Condition: Hepatitis C, Chronic
Intervention: Drug: Combination of pegylated interferon alfa-2b and ribavirin
12 Completed Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: UK-432,097;   Drug: Placebo
13 Recruiting A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365;   Drug: Placebo
14 Completed Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BI 1744CL
15 Recruiting Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
Conditions: Coronary Artery Disease (CAD);   Percutaneous Coronary Intervention (PCI)
Interventions: Drug: M118;   Drug: Unfractionated Heparin
16 Recruiting Study Evaluating the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Menopausal Women
Condition: Vasomotor Symptoms
Interventions: Drug: desvenlafaxine succinate (DVS) SR;   Drug: Placebo
17 Active, not recruiting Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM1)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir (SCH 503034);   Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908);   Drug: Boceprevir placebo
18 Recruiting Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: peg-interferon
19 Recruiting Effects of Rosuvastatin on Aortic Stenosis Progression
Condition: Aortic Stenosis
Interventions: Drug: Rosuvastatin;   Drug: Placebo
20 Active, not recruiting Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: leucovorin calcium;   Procedure: observation

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options